KT-US-679-0788: A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants with Relapsed/Refractory Multiple Myeloma
- Title
- A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants with Relapsed/Refractory Multiple Myeloma
- Principal Investigator
- Safi, Salah Ud Din
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Multiple Myeloma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Syed Abdul Mannan Shah
- Clinical Research Specialist
- Phone: +1 304-293-1683
- Email: syedabdulmannan.shah@hsc.wvu.edu